Melodiol Global Health Full Year 2023 Earnings: AU$0.019 Loss per Share (Vs AU$0.45 Loss in FY 2022)

Yahoo FinanceMar 1 17:42 ET

MELODIOL GLOBAL HEALTH LIMITED To Carry Out 1-for-20 Reverse Stock Split On January 25th, 2024

Moomoo NewsDec 22, 2023 19:50 ET

Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More

BenzingaJun 13, 2023 10:31 ET

Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia

BenzingaJun 9, 2023 14:27 ET

Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings

BenzingaMay 7, 2023 11:53 ET

Proactive News Headlines Including Antilles Gold, AuTECO Minerals, Latin Resources and HyTerra Ltd

GlobeNewswireJan 24, 2023 02:01 ET